UNIONDALE, NY / ACCESS Newswire / December 8, 2025 / Marquis Who’s Who, the trusted biographical authority documenting ...

ACT: As new ICH GCP guidelines roll out, how are sponsors balancing the drive for innovation—especially in areas like CAR-T ...

At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA ...

Technology maturity: Technology has reached a level of maturity that allows integration of various systems and devices to be seamless. Connected health devices and cloud platforms have evolved from ...

Proceeds to further advance clinical development of BH-30643, a first-in-class, macrocyclic, CNS-active, mutant-selective OMNI-EGFRTM inhibitor for EGFR-mutant NSCLC, and BH-30236, a novel macrocyclic ...

Chen: Yes, obesity is experiencing accelerated growth over the last couple of years. According to our sister product Evaluate ...

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...

Challenges in clinical trials are unique to each therapeutic area, whether patient recruitment or regulatory compliance. For example, oncology trials require precise endpoint definitions, while ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Innovative outcome measures coupled with a focus on patient-centered clinical differentiation can help the biopharma industry ...

At present evidence-based medicine is guided by the rules and regulations particularly of ethics and moral rights given which ...